Amicus is designed to fully replace multinationals’ subsidiaries in
those countries that the multinational chooses not to enter, or to exit.
Amicus is dedicated to service of research-based pharmaceutical and
healthcare companies who choose to enter the Balkans and the
Baltics in partnership, and not entirely with their own subsidiaries.
The company is staffed by a unique group of skilled managers and
medical professionals who are dedicated to bring modern medicines
to the people of our two regions. We are a service-oriented, high
quality and ethically-driven company.
Amicus was Founded in 2013 and is registered in Baar, Switzerland.
The company has 100%-owned affiliates in Bosnia & Herzegovina,
Croatia, Estonia, Kosovo, Latvia, Lithuania, Macedonia, Montenegro,
Serbia and Slovenia.
Both Amicus senior management and owners come from a heritage
of unique success in specialty pharmaceuticals in the Balkans and the
The company is financially strong – founding capital of 100,000 CHF.
Additional 19.000,000 Euros already committed. Founders have
pledged additional 3MM Euros against future capital calls;
Amicus enjoys strong financial connections with banks, hedge funds
and private equity – should the need or opportunity arise, we have
unsurpassed ability to raise capital quickly and efficiently.